A marked decrease in the activity of mitochondrial complex II (succinate dehydrogenase, SD) has been found in the brains of Huntington's disease (HD) patients. Here we have examined the possibility that SD inhibitors might produce their toxic action by increasing corticostriatal glutamatergic transmission. We report that SD inhibitors produce a durable augmentation of NMDA-mediated corticostriatal excitation (DANCE) in striatal spiny neurons, but not in striatal cholinergic interneurons. DANCE involves increased intracellular calcium, activation of MAP kinase ERK and is critically dependent upon endogenous dopamine (DA) acting via D2-like receptors. This pathological form of corticostriatal synaptic plasticity might play a key role in the regional and cell-type specific neuronal death observed in HD.

Centonze, D., Gubellini, P., Picconi, B., Saulle, E., Tolu, M., Bonsi, P., et al. (2001). An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease. NEUROLOGICAL SCIENCES, 22(1), 61-62 [10.1007/s100720170047].

An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease

CENTONZE, DIEGO;CALABRESI, PAOLO
2001-02-01

Abstract

A marked decrease in the activity of mitochondrial complex II (succinate dehydrogenase, SD) has been found in the brains of Huntington's disease (HD) patients. Here we have examined the possibility that SD inhibitors might produce their toxic action by increasing corticostriatal glutamatergic transmission. We report that SD inhibitors produce a durable augmentation of NMDA-mediated corticostriatal excitation (DANCE) in striatal spiny neurons, but not in striatal cholinergic interneurons. DANCE involves increased intracellular calcium, activation of MAP kinase ERK and is critically dependent upon endogenous dopamine (DA) acting via D2-like receptors. This pathological form of corticostriatal synaptic plasticity might play a key role in the regional and cell-type specific neuronal death observed in HD.
feb-2001
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/26 - NEUROLOGIA
English
Con Impact Factor ISI
Dopamine Antagonists; Synapses; Receptors, Dopamine D2; Cyclic AMP-Dependent Protein Kinases; Cell Death; Succinate Dehydrogenase; Rats; Neostriatum; Animals; Receptors, N-Methyl-D-Aspartate; Receptors, Dopamine D1; Calcium; Huntington Disease; Mitogen-Activated Protein Kinases; Cell Survival; Enzyme Inhibitors; Neuronal Plasticity; Cyclic AMP; Excitatory Postsynaptic Potentials; Dopamine Agonists; Dopamine
Centonze, D., Gubellini, P., Picconi, B., Saulle, E., Tolu, M., Bonsi, P., et al. (2001). An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease. NEUROLOGICAL SCIENCES, 22(1), 61-62 [10.1007/s100720170047].
Centonze, D; Gubellini, P; Picconi, B; Saulle, E; Tolu, M; Bonsi, P; Giacomini, P; Calabresi, P
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/50313
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 13
social impact